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Abstract 
La1 is a 73-residue cysteine-rich peptide isolated from the scorpion Liocheles australasiae 
venom. Although La1 is the most abundant peptide in the venom, its biological function 
remains unknown. Here, we describe a method for efficient chemical synthesis of La1 using 
the native chemical ligation (NCL) strategy, in which three peptide components of less than 
40 residues were sequentially ligated. The peptide-thioester necessary for NCL was 
synthesized using an aromatic N-acylurea approach with Fmoc-SPPS. After completion of 
sequential NCL, disulfide bond formation was carried out using a dialysis method, in which 
the linear peptide dissolved in an acidic solution was dialyzed against a slightly alkaline 
buffer to obtain correctly folded La1. Next, we determined the disulfide bonding pattern of 
La1. Enzymatic and chemical digests of La1 without reduction of disulfide bonds were 
analyzed by LC/MS, which revealed two of four disulfide bond linkages. Remaining two 
linkages were assigned based on MS/MS analysis of a peptide fragment containing two 
disulfide bonds. Consequently, the disulfide bonding pattern of La1 was found to be similar to 
that of a von Willebrand factor type C (VWC) domain. To our knowledge, this is the first 
report of the experimental determination of the disulfide bonding pattern of peptides having a 
single VWC domain as well as their chemical synthesis. La1 synthesized in this study will be 
useful for investigation of its biological role in the venom. 
 
Keywords: scorpion venom, peptide synthesis, native chemical ligation, disulfide bond, 
MS/MS  
 
  2 
Abbreviations: COMU, 
(1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium 
hexafluorophosphate; DIC, N,N’-diisopropylcarbodiimide; DIEA, 
N,N-diisopropylethylamine; ECM, extracellular matrix; Fmoc-Dbz, 
3-N-[(9H-fluoren-9-yl)methoxycarbonyl]-amino-4-aminobenzoic acid; HBTU, 
O-(benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; HOBt, 
1-hydroxybenzotriazole; Nbz, N-acybenzimidazolinone; NCL, native chemical ligation; SVC, 
single von Willebrand factor type C domain; Thz, 1,3-thiazolidine-4-carboxylic acid; TIS, 
triisopropylsilane; VWC, von Willebrand factor type C domain. 
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Introduction 
Scorpion venom contains a wide variety of biologically active peptides ranging in size 
from 0.4 to 10 kDa [1]. Peptides included in the scorpion venom can be classified into two 
main types based on the presence of disulfide bridges. The majority of scorpion peptides 
containing disulfide bridges are neurotoxic, which act on various ion channels in excitable 
membranes [2,3]. Peptides without disulfide bridges have also been identified from the 
venom of various scorpion species, which mainly shows antimicrobial activity [4,5]. These 
peptides play important roles in the scorpion venom to capture prey or to defend against 
predators or pathogens, but the peptides identified and characterized so far are only a fraction 
of all venom components. Thus, a large number of peptides whose biological activity is 
unknown are included in the scorpion venom [1].  
La1, which was isolated from the Liocheles australasiae venom, is one example of the 
“neglected” components [6]. La1 is the most abundant component in the L australasiae 
venom, but its biological role has not been determined yet. Interestingly, peptides similar to 
La1 have been identified from the venom of various scorpion species, suggesting that La1 and 
its related peptides (La1-like peptides) may play an important role in the scorpion venom 
[7-11]. In terms of structure, it has been presumed that La1-like peptides possess a single von 
Willebrand factor type C (VWC) domain based on the position of eight Cys residues [12], 
although their disulfide bonding pattern has yet to be determined experimentally. 
To investigate the possible biological function of the neglected components including 
La1, milligram scale of the sample is often necessary for conducting various experiments. 
Since the amount of La1 available from the venom is not sufficient for this purpose, a method 
for its large-scale preparation must be established. La1 consists of 73 amino acid residues 
(Figure 1), and it could be prepared either by chemical synthesis or by recombinant 
expression. Chemical synthesis is generally superior to recombinant expression in terms of 
yields, thanks to the recently established native chemical ligation (NCL) technique [13]. NCL 
enables the chemoselective condensation of two unprotected peptides with readily 
synthesizable length. The chemical method also allows the incorporation of non-natural 
amino acids in the sequence. Here, we report the efficient chemical synthesis of La1 using 
NCL. Moreover, the disulfide bonding pattern of La1 was investigated. The pattern was 
determined using natural La1, and compared it with that of synthetic La1 to confirm that the 
folding reaction proceeded correctly. To our knowledge, this is the first report of the 
experimental determination of their disulfide bonding pattern of peptides having single VWC 
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domain (SVC) including La1 as well as their chemical synthesis. 
 
Materials and methods 
Materials 
Natural La1 was purified from the venom of the scorpion Liocheles australasiae reared in 
our laboratory [6]. Fmoc- or Boc-protected amino acids, Fmoc-NH-SAL resin, 
Fmoc-NH-SAL-PEG resin, triisopropylsilane (TIS), N,N’-diisopropylcarbodiimide (DIC), 
O-(benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), 
1-hydroxybenzotriazole (HOBt), and 
(1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium 
hexafluorophosphate (COMU) were purchased from Watanabe Chemical Industries 
(Hiroshima, Japan). 3-N-[(9H-fluoren-9-yl)methoxycarbonyl]-amino-4-aminobenzoic acid 
(Fmoc-Dbz) was synthesized according to the literature [14]. Trypsin (mass spectrometry 
grade) was purchased from Wako Pure Chemical Industries (Osaka, Japan). All other 
chemicals were commercially available. 
 
HPLC 
Preparative RP-HPLC was carried out using a preparative column, Inertsil ODS-3, 250 × 
20 mm ID (GL Sciences) at a flow rate of 7 ml/min, or InertSustain C18, 250 × 14 mm ID 
(GL Sciences) at a flow rate of 5 ml/min, using a 60 min linear gradient from 10 to 40% of 
solvent B (CH3CN containing 0.1% TFA) in solvent A (H2O containing 0.1% TFA) at 40°C. 
Elution was monitored by absorption at 215 nm. Analytical RP-HPLC was carried out using a 
micro column, Vydac Everest C18, 250 × 1.0 mm ID (Grace Vydac, Hesperia, CA, USA) at a 
flow rate of 50 µl/min, using a 50 min linear gradient from 5 to 50% of solvent B in solvent A 
at 40°C. Elution was monitored by absorption at 215 nm. 
 
Mass spectrometry 
LC/MS analysis to monitor reactions was performed on an LCMS-2020 mass 
spectrometer (Shimadzu, Kyoto, Japan) equipped with an electrospray ion source in the 
positive mode. HPLC separation was carried out using a semi-micro column, InertSustatin 
C18, 150 x 2.1 mm ID (GL Sciences, Tokyo, Japan). The column was eluted at a flow rate of 
0.2 ml/min with 0.1% formic acid in water (solvent C) and 0.1% formic acid in acetonitrile 
(solvent D) with a 20 min linear gradient of 5 to 50% solvent D in solvent C. Elution was also 
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monitored by absorption at 215 nm. LC/MS analysis for high-resolution measurements was 
performed on an LCMS-IT-TOF mass spectrometer (Shimadzu) equipped with an 
electrospray ion source in the positive mode. HPLC separation was carried out on a micro 
column, TSKgel ODS-100V, 150 x 1.0 mm ID (Tosoh, Tokyo, Japan). The column was eluted 
at a flow rate of 50 µl/min with a 25 min linear gradient of 5 to 50% solvent D in solvent C. 
MALDI-TOF-MS/MS measurements were carried out on an Autoflex III mass 
spectrometer (Bruker Daltonics, Billerica, MA). The sample was dissolved in a matrix 
solution containing 10 mg/ml of α-cyano-4-hydroxycinnamic acid, 70% acetonitrile and 0.1% 
TFA, and 0.5 µl of the solution was spotted on the MALDI sample target and allowed to dry 
at room temperature. External calibration of the mass scale was carried out using peptides 
with known molecular masses. MS/MS measurements were carried out in the LIFT mode.  
 
Synthesis 
General procedure for solid-phase peptide synthesis  
Peptides were manually synthesized by using the Fmoc-based solid-phase peptide 
synthesis (SPPS) technique. Fmoc deprotection was performed with 20% piperidine in 
N,N-dimethylformamide (DMF) three times, each for 3, 3, and 20 min at room temperature. 
Each Fmoc-protected amino acid (3 eq) were coupled in the presence of COMU (3 eq) and 
N,N-diisopropylethylamine (DIEA, 3 eq) in DMF under microwave heating (Initiator+, 
Biotage, Uppsala, Sweden) at 75°C for 5 min. For introduction of Cys and 
1,3-thiazolidine-4-carboxylic acid (Thz), DIC (3 eq) and HOBt (3 eq) were used and reacted 
for 20 min with microwave heating at 50°C. The reaction was monitored by Kaiser test. After 
completion of coupling reaction, the resin was sequentially washed with DMF, diethyl ether 
and methanol, and dried in vacuo. Cleavage of peptides from the resin and removal of 
side-chain protecting groups were carried out using the solution containing 
TFA/triisopropylsilane/1,3-dimethoxybenzene (92.5: 2.5: 5, v/v/v), which was reacted for 2 h 
at room temperature. After the resin was removed by filtration, cold diethyl ether was added 
to the filtrate to precipitate the peptides, followed by washing with cold diethyl ether twice 
and drying in vacuo. 
 
Synthesis of La1(43-73)   
Fmoc-NH-SAL-PEG resin (0.24 mmol/g substitution) was used for the synthesis. After 
peptide chain assembly and removal of the N-terminal Fmoc group were completed, cleavage 
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of peptides from the resin and removal of side-chain protecting groups were performed as 
described above. The desired peptide was purified by HPLC and lyophilized. La1(43-73) was 
obtained in 27% yield (92 mg) based on the amount of the resin used. ESI-MS: observed m/z 
751.4 for [M+4H]4+ (calcd. m/z 751.4). 
 
[Thz29]La1(29-42)-thioester 
Fmoc-NH-SAL resin (0.56 mmol/g substitution) was used for the synthesis. Introduction 
of the C-terminal Dbz residue and the following Arg residue was performed using longer 
reaction time (20 min). Thz was incorporated at the position of Cys29. After peptide chain 
assembly was completed, the solution of p-nitrophenylchloroformate (2 mg/ml) in 
dichloromethane was added to the resin. After reaction for 1 h at room temperature, the resin 
was washed with dichloromethane and DMF. The resin was reacted with DIEA (0.5 M) in 
DMF for 30 min at room temperature, and washed with DMF and methanol. After cleavage of 
peptides from the resin and removal of side-chain protecting groups were performed, the 
peptide was treated with 2% methyl 3-mercaptopropionate in 200 mM Na2HPO4 (adjusted to 
pH 7.1 with HCl) containing 6 M guanidine•HCl for 1 h at room temperature to obtain 
peptide thioester. The desired peptide-thioester was purified by HPLC and lyophilized. 
[Thz29]La1(29-42)-thioester was obtained in 31% yield (157 mg) based on the amount of the 
resin used. ESI-MS: observed m/z 458.1 for [M+4H]4+ (calcd. m/z 458.1). 
 
La1(1-28)-thioester 
Fmoc-NH-SAL-PEG resin (0.24 mmol/g substitution) was used for the synthesis. 
Introduction of the C-terminal Dbz residue and the following Lys residue was performed 
using longer reaction time (20 min). The Boc-protected amino acid was used for the 
N-terminal Phe residue. Further procedure was identical to that of synthesis of 
[Thz29]La1(29-42)-thioester. La1(1-28)-thioester was obtained in a 14% yield (92 mg) based 
on the amount of the resin used. ESI-MS: observed m/z 805.4 for [M+4H]4+ (calcd. m/z 805.5) 
 
Native chemical ligation between [Thz29]La1(29-42)-thioester and La1(43-73) 
Ligations were performed in a buffer containing guanidine•HCl (6 M), 
tris(2-carboxyethyl)phosphine hydrochloride (TCEP•HCl, 20 mM), 4-mercaptophenylacetic 
acid (MPAA, 100 mM), Na2HPO4 (200 mM), adjusted to pH 7 with NaOH. 
[Thz29]La1(29-42)-thioester and La1(43-73) was dissolved in the ligation buffer at final 
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concentrations of approximately 1 and 0.5 mM, respectively, considering the presence of the 
impurities and the possibility of hydrolysis of the thioester moiety of the former peptide. The 
reaction mixture was stirred at room temperature for 2 h, and the progress of the ligation was 
monitored by LC/MS. To this mixture, methoxyamine hydrochloride (400 mM) was added to 
convert the N-terminal Thz to Cys. After reaction for 5 h, ligation product was purified by 
HPLC and lyophilized. A total of 77 mg (58-76%) of La1(29-73) was obtained. ESI-MS: 
observed m/z 783.9 for [M+6H]6+ (calcd. m/z 784.0). 
 
Ligation between La1(1-28)-thioester and La1(29-73) 
La1(1-28)-thioester and La1(29-73) were dissolved in the ligation buffer at final 
concentrations of approximately 0.9 and 0.6 mM, respectively. Further ligation procedure was 
identical to that between [Thz29]La1(29-42)-thioester and La1(43-73) except that treatment 
with methoxyamine hydrochloride was omitted. Ligation product was purified by HPLC and 
lyophilized. A total of 20 mg (14-25%) of linear La1 was obtained. ESI-MS: observed m/z 
867.1 for [M+9H]9+ (calcd. m/z 867.1). 
 
Folding 
Disulfide bridge formation was carried out by the oxidative dialysis method [15]. Linear 
La1 (0.13 mg/ml) dissolved in 10% (v/v) acetic acid was loaded into a dialysis cassette 
(Slide-A-Lyzer G2, 3500 MWCO, 30 ml, Thermo Scientific, Rockford, IL) and dialyzed 
twice against 2 L of 100 mM phosphate buffer (pH7.7) containing NaCl (100 mM), 
guanidine•HCl (20 mM), and reduced (1 mM) and oxidized glutathione (0.1 mM) for 72 h. 
The folded peptide was purified by HPLC and lyophilized. Pure La1 was obtained in 41% 
(5.2 mg) yield. HR-ESI-MS: observed m/z 865.63 for [M+9H]9+ (calcd. m/z 865.65) 
 
Determination of disulfide bonding pattern 
Natural or synthetic La1 (50 µg) was dissolved in 0.1 M NH4HCO3 buffer (adjusted to 
pH 6.6 with HCl), and digested with trypsin (0.5 µg/µl) at 37°C for 20 h. Digested peptides 
were analyzed by LC/MS, and the peptide containing three disulfide bonds was purified by 
HPLC and lyophilized. The peptide was dissolved in 0.1 M HCl, and reacted with an excess 
amount of CNBr for 20 h at room temperature. CNBr was removed by a C18 spin column 
(MonoSpin C18, GL Sciences), and the resultant digests were subjected to MS and MS/MS 
analysis using MALDI-TOF/TOF MS. 
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Results and discussion 
Synthesis of La1 using NCL 
Since the limit of the linear stepwise elongation in SPPS is around 50 residue-long, 
synthesis of a 73-residue peptide, La1, would be difficult using a general SPPS approach. To 
overcome this limitation, several techniques for synthesis of large peptides consisting of over 
50 residues have been developed. Chemical ligation is one of the efficient methods to obtain 
large peptides, in which two or more peptide segments with readily synthesizable length are 
ligated [16]. Among them, an NCL approach is one of the most promising methods for the 
synthesis of large peptides. NCL allows the chemoselective coupling of an unprotected 
peptide having a C-terminal thioester moiety with another unprotected peptide bearing an 
N-terminal Cys residue, in which intermolecular thioester exchange occurs first between the 
thioester moiety and the thiol group of the Cys residue, followed by spontaneous S-N acyl 
transfer to form an amide bond [13]. Since a Cys residue is essential for ligation, NCL is 
particularly suitable for synthesis of Cys-rich peptides such as scorpion peptides. In this study, 
an NCL approach was, therefore, applied to the synthesis of La1.  
The strategy for the synthesis of La1 is shown in Figure 2. La1 was synthesized using 
two sequential NCL from three segments (Table 1). The peptide having a thioester moiety at 
the C-terminus was synthesized through Dawson’s method [14]. In this method, 
3,4-diaminobenzoic acid (Dbz), which is stable under alkaline conditions, is used during 
peptide chain elongation using Fmoc-SPPS, and then converted into the 
N-acybenzimidazolinone (Nbz) moiety before cleavage of peptides from resin. The Nbz 
moiety is finally substituted with reactive thiols to afford a peptide thioester. Since eight Cys 
residues are present in the sequence of La1, there are many possible ligation sites for NCL. 
We initially chose the site between Arg42 and Cys43 for first ligation and that between Asp23 
and Cys24 for second ligation. However, preparation of the segment La1(1-23)-Nbz necessary 
for second ligation was not successful, where only the peptide having a free carboxylate 
group at the C-terminus was obtained. This is likely because of the presence of the Asp 
residue adjacent to the Nbz moiety. The side chain carboxylate anion of the Asp residue could 
attack its carbonyl group in the main chain to remove the Nbz moiety. Therefore, we chose 
the site between Lys28 and Cys29 for second ligation.  
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Synthesis of each segment 
The C-terminal segment, La1(43-73), was synthesized using the general Fmoc-SPPS 
method. After HPLC purification, the desired peptide was obtained in 27% yield (Figure 3a). 
The central segment [Thz29]La1(29-42)-thioester, which contains a thioester moiety at the 
C-terminus and a Thz residue at the N-terminus, was synthesized by Fmoc-SPPS starting 
from introduction of Dbz at the C-terminus. After peptide chain elongation, Dbz was 
converted to Nbz on the resin. The peptide-Nbz was cleaved from the resin, and treated with 
methyl 3-mercaptopropionate at neutral pH to obtain a peptide-thioester. After HPLC 
purification, the desired peptide was obtained in 31% yield (Figure 3b). In this synthesis, 
several impurities caused by the incorporation of amino acid residues at another amino group 
of the Dbz moiety were observed even after HPLC purification. However, since these 
peptides cannot participate in the NCL reaction due to the lack of the C-terminal thioester 
moiety and the N-terminal Cys residue, this was used without further purification. The 
synthesis of the N-terminal segment La1(1-28)-thioester was performed using the method 
similar to that of [Thz29]La1(29-42)-thioester. In this case, the peptide with a molecular mass 
of 120 Da smaller than the desired one was observed before HPLC purification. This is likely 
to be a peptide containing a cyclic structure formed in the C-terminal Lys residue, which 
could be caused by the nucleophilic attack of the side chain amino group of the Lys residue on 
the carbonyl carbon in the C-terminal thioester moiety. This side product was removed by 
HPLC. Finally the desired peptide was obtained in 14% yield (Figure 3c). 
 
Ligation reaction 
First ligation was carried out between [Thz29]La1(29-42)-thioester and La1(43-73). As 
shown in Figure 4a, reaction was completed within 2 h, which was monitored by LC/MS. To 
this solution, methoxyamine hydrochloride was added, and Thz was successfully converted 
into Cys after 5 h. The ligated peptide La1(29-73) was partially purified by HPLC in 76% 
yield (Figure 4b and 4c), and subjected to second ligation with La1(1-28)-thioester. The result 
of second ligation was shown in Figure 5a. After reaction for 2 h, the ligated product (linear 
La1) was observed along with the disappearance of La1(1-28)-thioester. A large amount of 
La1(29-73) remained even after completion of the reaction. This is because some part of 
La1(1-28)-thioester was converted to its side product, in which the C-terminal Lys could be 
intermolecularly cyclized as described above. After HPLC purification, linear La1 was 
successfully obtained (Figure 5b and 5c), although the yield of the second ligation was rather 




Disulfide bridge formation is often carried out under slightly alkaline conditions. 
However, linear La1 was sparingly soluble in aqueous buffer at pH 8.5, but dissolved readily 
in acidic solution. This prompted us to perform disulfide bridge formation of La1 under acidic 
conditions. We first attempted the oxidation reaction mediated by dimethyl sulfoxide (DMSO), 
which is known to proceed under acidic conditions [17]. La1 was dissolved in 5% aqueous 
acetic acid in the presence of DMSO (20% by volume), and reacted for 48 h. LC/MS analysis 
of the reaction mixture showed that multiple peaks having a molecular mass of fully oxidized 
La1 were observed (data not shown). This indicated that peptides having incorrect disulfide 
linkages were mainly generated under this condition. We speculated that the acidic 
environment could have an adverse effect on correct folding of La1. To allow the peptide that 
is only soluble in an acidic environment to form disulfide bridges under alkaline conditions, a 
dialysis method have been developed [15]. In this method, the peptide was dissolved in acidic 
solution and dialyzed against alkaline buffer to promote correct folding. We applied this 
method to the folding of La1. Linear La1 was dissolved in 10% aqueous acetic acid, and 
dialyzed twice against 100 mM phosphate buffer (pH 7.7) containing oxidized and reduced 
glutathione for 72 h. From the result of HPLC analysis, a large main peak was observed, 
which has a molecular mass of fully oxidized La1 (Figure 6a). In addition to this peak, 
peptides with a 611 Da larger mass were observed as a broad peak. This is probably due to 
incorporation of glutathione molecules via a disulfide bond at two different Cys residues. The 
main peak was purified by HPLC in 41% yield. The identity of this peptide was confirmed by 
comparison with natural La1. Both synthetic and natural La1 showed the same retention time 
in HPLC analysis (Figure 6b). The monoisotopic molecular mass of synthetic La1 (7781.63 
Da) determined by high-resolution LC/MS analysis (Figure 6c) is in good agreement with the 
calculated one (7781.76 Da).  
 
Determination of disulfide bonding pattern 
Disulfide bonding patterns of peptides are often determined by MS analysis, in which 
enzymatically and/or chemically digested fragments of the peptides without reduction of 
disulfide bonds are analyzed. To assign each disulfide linkage, the peptide chain must be 
cleaved at every sequence region between Cys residues, which generates peptide fragments 
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consisting of a pair of peptides cross-linked by a single disulfide bond. Based on the 
molecular masses of these fragments detected by MS analysis, disulfide linkages can be 
assigned. In the case of La1, all regions between Cys residues can be cleaved by combination 
of trypsin and CNBr, except for the region between Cys66 and Cys67. Since these two Cys 
residues are adjacently located, cleavage between these Cys residues is difficult by using 
commercially available enzymes or chemical methods. Therefore, we employed a MS/MS 
technique for assignment of the disulfide linkages involving these two Cys residues.  
We first analyzed the tryptic digests of natural La1 using LC/MS (Figure 7). A fragment 
that corresponds to two peptide chains cross-linked by a disulfide bond between Cys5 and 
Cys29 was detected. In addition, a fragment consisting of four peptide chains cross-linked 
each other by three disulfide bonds was observed. Since this fragment contains a Met residue 
in the sequence between Cys67 and Cys72, it was further digested using CNBr after HPLC 
purification. MALDI-TOF MS analysis of the CNBr digests detected two peptide fragments; 
one (m/z 841.4) consisting of two peptide chains (SGCK and VTCK) linked by a disulfide 
bond between Cys52 and Cys72, and the other (m/z 2872.3) consisting of three peptide chains 
(TVPGGAGAAFPSCCPh, CATVNLK and DCALYK) linked each other by two disulfide 
bridges (data not shown). The latter was further subjected to MS/MS analysis using 
MALDI-TOF/TOF MS to assign disulfide bond linkages. As shown in Figure 8, two major 
product ions (m/z 2044.0 and 2672.0) were observed in the product ion spectrum, which 
correspond to the fragments cleaved at the N-terminal side of Pro residues. By careful 
inspection of this spectrum, fragment ions generated by cleavage of the main chain between 
Cys66 and Cys67 were observed, which allowed the distinction between two possible 
linkages of disulfide bonds. A fragment ion with m/z of 1047.5 corresponds to the peptide 
chains containing a disulfide bond between Cys43 and Cys67. The presence of another 
disulfide bond between Cys24 and Cys66 was also confirmed by detection of a fragment ion 
with m/z of 997.3, although its intensity was relatively low. This assignment was further 
supported by the absence of fragment ions containing a disulfide bond between Cys43 and 
Cys66 (m/z 1033.5) or between Cys24 and Cys67 (m/z 1011.4). Consequently, all four 
disulfide bond linkages included in La1 were assigned (Figure 9a). When these experiments 
were carried out using synthetic La1, the same result was obtained (data not shown), 
indicating that the synthetic La1 has the same disulfide bonding pattern as natural one. As 
expected, La1 has the disulfide bonding pattern similar to that of the VWC domain in ECM 
proteins, although one disulfide bond between third Cys and fifth Cys is missing in La1 as 
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shown in Figure 9b [18]. This suggests that La1 has similar conformation to the VWC domain 
in ECM proteins. Currently, X-ray structural analysis of La1 is in progress to confirm this 
hypothesis [19]. 
The VWC domain is an extremely common motif found in various extracellular matrix 
(ECM) proteins including von Willebrand factor, CCN (cysteine-rich protein 61, connective 
tissue growth factor proteins, nephroblastoma overexpressed gene), procollagen, 
thrombospondin, glycosylated mucins, and neuralins [20]. Although the biological roles of 
the VWC domain are not fully understood, this domain has been reported to be important for 
oligomerization or binding to other proteins [21,22]. In arthropods, a peptide family that 
possesses a single VWC domain (SVC) has been identified [12]. Although the biological 
function of the arthropod SVC peptides remains to be investigated, some of them are induced 
by certain environmental stresses such as pathogen infection [23]. In this regard, it is possible 
that La1 could play a role in defense against pathogens.  
 
Conclusions 
La1 is a 73-residue peptide containing four disulfide bonds. In this study, we established 
a method for chemical synthesis of La1 using an NCL strategy, in which three peptide 
segments of less than 40 residues were sequentially ligated. Each peptide-thioester necessary 
for NCL was synthesized using an aromatic N-acylurea approach with Fmoc SPPS. Linear 
La1 obtained by sequential NCL was then oxidized to form the four disulfide bonds using a 
dialysis method, which allowed the correct folding of La1. Furthermore, the disulfide bonding 
pattern of La1 was determined by MS and MS/MS analysis. MS analysis of enzymatic and 
chemical digests of La1 without reduction revealed two of four disulfide bonds linkages. 
Remaining two disulfide bond linkages were assigned by MS/MS analysis of the peptide 
fragment containing two disulfide bonds. The disulfide bonding pattern of La1 was found to 
be similar to that of a VWC domain in ECM proteins. To our knowledge, this is the first 
report of the determination of the disulfide bonding pattern of peptides having a SVC domain. 
La1 synthesized by the method established in this study will be useful for future investigation 
of its biological roles in the venom. 
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Table 1  Structure of peptide segments used for native chemical ligation 
 
Peptide Sequence Molecular mass (Da) 
La1(1-28)-thioester FGESCIAGRFIVPLGQQVTDQRDCALYK-CO-S(CH2)2COOCH3 3217.8 
[Thz29]La1(29-42)-thioester [Thz]VNYNKKFALETKR-CO-S(CH2)2COOCH3 1828.2 
La1(43-73) CATVNLKSGCKTVPGGAGAAFPSCCPMVTCK-NH2 3001.7 
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Figure legends 
 
Fig. 1  Amino acid sequence of La1. Asterisk indicates an amidated C-terminus. Arrows 
indicate the ligation sites. 
 
Fig. 2  Synthesis of La1 through sequential NCL. 
 
Fig 3  HPLC analysis of peptide segments after partial purification. La1(43-73) (a), 
[Thz29]La1(29-41)-thioester (b), and La1(1-28)-thioester (c). An asterisk indicates impurities. 
 
 
Fig 4  HPLC analysis of 1st ligation (a). UV chromatogram (b) and mass spectrum (c) of 
partially purified La1(29-73). 
 
Fig 5  HPLC analysis of 2nd ligation (a). UV chromatogram (b) and mass spectrum (c) of 
purified linear La1 
 
Fig 6  HPLC analysis of folding reaction (a) and comparison of retention time between 
synthetic and natural La1 (b). Asterisks indicate La1 containing an oxidized Met residue. MS 
analysis of synthetic La1 (c). The deconvoluted spectrum is shown in the inset. 
 
Fig 7  LC/MS analysis of tryptic digests of La1 without reduction of disulfide bonds. TIC 
chromatogram is shown. 
 
Fig 8  MS/MS analysis of the peptide fragment containing two disulfide bonds. The letter “h” 
in the peptide sequence denotes homoserine lactone. 
 
Fig 9  Disulfide bonding pattern of La1 (a) and its comparison with that of chordin-like 
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43CATVNLK 
PGGAGAAFPS66C67CPh
43CATVNLK 
D24CALYK 
PS66C67CPh
43CATVNLK 
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2044.0
2672.0
TVPGGAGAAFPS66C67CPh
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Fig.%8%%MS/MS%analysis%of%the%pep5de%fragment%containing%two%disulfide%bonds.%
The%le?er%“h”%in%the%pep5de%sequence%denotes%homoserine%lactone.%
YVEFQEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIICEDVKDCLSPEIPFGECCPICPADLAAAA
Fig.6966Disulfide6bonding6paCern6of6La16(a)6and6its6comparison6with6that6of6
chordinNlike6cysteineNrich6repeat6from6collagen6IIA6(b).6The6disulfide6bond6
shown6in6red6is6missing6in6La1.
FGESCIAGRFIVPLGQQVTDQRDCALYKCVNYNKKFALETKRCATVNLKSGCKTVPGGAGAAFPSCCPMVTCK
a)
b)
